PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Penumbra Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$322.41+1.55 (+0.48%)
Close on Oct 19, 2026
- Market cap
- $12.76B
- P/E (TTM)
- 79.2
- Dividend yield
- –
Penumbra Inc balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 67.8%
- Operating margin
- 12.4%
- Net margin
- 10.7%
- Return on equity, FY2025
- 13.8%
Financial strength
- Current ratio
- 5.75
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 87.8%
Valuation
- P/E ratio
- 79.2
- Price to sales
- 8.48
- Price to book
- 8.33
- Dividend yield
- –